Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncopeptides Major Shareholding Notification 2018

Apr 4, 2018

3091_iss_2018-04-04_5728afd2-5d06-4a4c-b7c7-737ae6d93c46.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Oncopeptides AB

Holder

Stiftelsen Industrifonden

Instrument

Instrument Ordinary Shares SE0009414576
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Share loan
Date 03/04/2018
Limit for number of shares 25 %
Limit for number of votes 25 %
After the transaction
Quantity
Shares 11,620,805
Directly held voting rights 11,620,805
Indirectly held voting rights 0
Percentage
Directly held shares 26.53999 %
Directly held voting rights 26.53999 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 26.53999 % 11,620,805
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 26.53999 % 11,620,805
Group total holdings
Voting rights
11,620,805
Percentage of voting rights 26.53999

Notes (other relevant informations according to law)

Flaggningen avser återleverans av utlånade aktier i samband med nyemission i Oncopeptides. Flaggningen är baserad på 43 786 021 utestående aktier i Oncopeptides per den 3 april 2018, dagen då flaggningsskyldigheten uppstod.

Published

04/04/2018 08:51

Contact

Name Jonas Brambeck

Phone +46708791937 Email [email protected]

*Source of information has chosen not to submit the data

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25